John Tierney at the New York Times writes that the fierce debate over the corrupting influence of corporate money in scientific research has become a fetish that is pushing some of the country's top researchers to stop accepting any support from drug companies. To rebalance the scales, he suggests that scientists simply detail all public and private donors on their Web pages and let journalists sort through them, leaving it to readers to decide if there is a conflict. Report